PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10395082-7	1999	AVP evoked an increase in [Ca2+]i levels (162 +/- 12 nmol/L from a basal value of 77 +/- 6 nmol/L) which was completely abolished by pretreatment with either NCDC or cyclopiazonic acid (sarcoplasmic reticulum (SR) Ca2+ pump inhibitor) but unaffected by ryanodine (ryanodine sensitive SR Ca2+ store depletor).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	158-162	arginine vasopressin	Rattus norvegicus	0-3	
10511129-6	1999	The phospholipase C inhibitors, D-609, NCDC, or U73122, and the IP3 receptor blocker, heparin, abolished the [Ca2+]i response to AVP.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	39-43	arginine vasopressin	Rattus norvegicus	129-132	
10395082-4	1999	The stimulating action of AVP on [3H] phenylalanine incorporation was abolished by pretreatment with 2-nitro-4carboxyphenyl-N, N-diphenylcarbamate (NCDC), a phospholipase C (PLC) inhibitor.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	101-146	arginine vasopressin	Rattus norvegicus	26-29	
10395082-4	1999	The stimulating action of AVP on [3H] phenylalanine incorporation was abolished by pretreatment with 2-nitro-4carboxyphenyl-N, N-diphenylcarbamate (NCDC), a phospholipase C (PLC) inhibitor.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	148-152	arginine vasopressin	Rattus norvegicus	26-29